Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Genetic Technologies ROA 2006-2019 | GENE

Current and historical return on assets (ROA) values for Genetic Technologies (GENE) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Genetic Technologies ROA for the three months ending December 31, 2019 was 0.00%.
  
Genetic Technologies ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.018B $0.000B
Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $132.244B 14.56
Gilead Sciences (GILD) United States $93.953B 12.18
CSL (CSLLY) Australia $87.268B 0.00
Vertex Pharmaceuticals (VRTX) United States $72.211B 49.65
Regeneron Pharmaceuticals (REGN) United States $59.851B 23.07
Illumina (ILMN) United States $53.482B 54.96
Biogen (BIIB) United States $49.195B 8.42
Seattle Genetics (SGEN) United States $26.479B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.439B 10.07
Incyte (INCY) United States $21.350B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.386B 0.00
Genmab (GMAB) Denmark $19.382B 15.96
Moderna (MRNA) United States $19.370B 0.00
BioMarin Pharmaceutical (BMRN) United States $19.295B 174.92
Genmab (GNMSF) Denmark $18.186B 53.99
Alnylam Pharmaceuticals (ALNY) United States $15.311B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Galapagos (GLPG) Belgium $12.821B 37.96
BeiGene (BGNE) Cayman Islands $12.445B 0.00
Exact Sciences (EXAS) United States $12.296B 0.00
Sarepta Therapeutics (SRPT) United States $12.257B 0.00
BioNTech SE (BNTX) Germany $10.768B 0.00
Bio-Techne Corp (TECH) United States $9.834B 64.97
QIAGEN (QGEN) Netherlands $9.798B 28.49
Horizon Therapeutics Public (HZNP) Ireland $9.367B 23.05
ARGENX SE-ADR (ARGX) Netherlands $9.141B 0.00
Guardant Health (GH) United States $8.297B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.891B 0.00
Immunomedics (IMMU) United States $7.890B 0.00
Exelixis (EXEL) United States $7.482B 26.24
Ascendis Pharma (ASND) Denmark $7.047B 0.00
Repligen (RGEN) United States $6.699B 117.50
Acceleron Pharma (XLRN) United States $5.356B 0.00
Reata Pharmaceuticals (RETA) United States $5.078B 0.00
MyoKardia (MYOK) United States $4.994B 0.00
Adaptive Biotechnologies (ADPT) United States $4.959B 0.00
Mirati Therapeutics (MRTX) United States $4.540B 0.00
Emergent Biosolutions (EBS) United States $4.411B 28.91
Global Blood Therapeutics (GBT) United States $4.303B 0.00
China Biologic Products (CBPO) China $4.256B 23.66
Ultragenyx Pharmaceutical (RARE) United States $4.242B 0.00
MorphoSys AG (MOR) Germany $4.234B 32.84
Zai Lab (ZLAB) China $3.919B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.901B 85.24
Momenta Pharmaceuticals (MNTA) United States $3.836B 0.00
Vir Biotechnology (VIR) United States $3.796B 0.00
Blueprint Medicines (BPMC) United States $3.485B 0.00
Bluebird Bio (BLUE) United States $3.432B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.276B 0.00
Halozyme Therapeutics (HALO) United States $3.255B 0.00
Amicus Therapeutics (FOLD) United States $3.208B 0.00
NeoGenomics (NEO) United States $3.006B 219.54
Arena Pharmaceuticals (ARNA) United States $2.927B 0.00
UniQure (QURE) Netherlands $2.906B 0.00
Denali Therapeutics (DNLI) United States $2.892B 0.00
Amarin (AMRN) Ireland $2.683B 0.00
Alkermes (ALKS) Ireland $2.658B 52.33
Novavax (NVAX) United States $2.635B 0.00
Viela Bio (VIE) United States $2.630B 0.00
Alector (ALEC) United States $2.588B 0.00
Insmed (INSM) United States $2.582B 0.00
Fate Therapeutics (FATE) United States $2.571B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.452B 0.00
Principia Biopharma (PRNB) United States $2.243B 0.00
Inovio Pharmaceuticals (INO) United States $2.085B 0.00
Epizyme (EPZM) United States $1.904B 0.00
Eidos Therapeutics (EIDX) United States $1.869B 0.00
Zymeworks (ZYME) Canada $1.777B 0.00
Ligand Pharmaceuticals (LGND) United States $1.682B 65.48
Adverum Biotechnologies (ADVM) United States $1.681B 0.00
Arvinas (ARVN) United States $1.679B 0.00
Sangamo Therapeutics (SGMO) United States $1.611B 0.00
REGENXBIO (RGNX) United States $1.581B 0.00
Twist Bioscience (TWST) United States $1.554B 0.00
Mesoblast (MESO) Australia $1.533B 0.00
Editas Medicine (EDIT) United States $1.532B 0.00
Akcea Therapeutics (AKCA) United States $1.524B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.507B 0.00
Intra-Cellular Therapies (ITCI) United States $1.463B 0.00
I-Mab (IMAB) China $1.384B 0.00
NGM Biopharmaceuticals (NGM) United States $1.383B 0.00
Zealand Pharma (ZEAL) Denmark $1.372B 0.00
PHARMA MAR SA (PHMMF) Spain $1.363B 0.00
Coherus BioSciences (CHRS) United States $1.358B 9.48
Beam Therapeutics (BEAM) United States $1.266B 0.00
Cytokineticsorporated (CYTK) United States $1.263B 0.00
Revance Therapeutics (RVNC) United States $1.258B 0.00
Arcus Biosciences (RCUS) United States $1.246B 0.00
Myriad Genetics (MYGN) United States $1.088B 56.12
Sorrento Therapeutics (SRNE) United States $1.084B 0.00
Mersana Therapeutics (MRSN) United States $1.072B 0.00
NextCure (NXTC) United States $0.950B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.942B 0.00
Athenex (ATNX) United States $0.936B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.933B 0.00
Intellia Therapeutics (NTLA) United States $0.917B 0.00
Compugen (CGEN) Israel $0.903B 0.00
Pharming Group (PHGUF) Netherlands $0.901B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Heska (HSKA) United States $0.817B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.802B 0.00
Cellectis S.A (CLLS) France $0.801B 0.00
Cue Biopharma (CUE) United States $0.772B 0.00
Alcobra (ARCT) United States $0.767B 0.00
Cara Therapeutics (CARA) United States $0.752B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.748B 0.00
NantKwest (NK) United States $0.747B 0.00
Kadmon Holdings (KDMN) United States $0.733B 0.00
Codexis (CDXS) United States $0.726B 0.00
Morphic Holding (MORF) United States $0.697B 0.00
Retrophin (RTRX) United States $0.697B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.686B 0.00
Kala Pharmaceuticals (KALA) United States $0.672B 0.00
Castle Biosciences (CSTL) United States $0.659B 0.00
Vericel (VCEL) United States $0.646B 119.25
Sinovac Biotech (SVA) China $0.640B 17.03
Bellus Health (BLU) Canada $0.631B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.622B 0.00
Stemline Therapeutics (STML) United States $0.618B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.608B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.607B 5.20
MeiraGTx Holdings (MGTX) United States $0.597B 0.00
Scholar Rock Holding (SRRK) United States $0.576B 0.00
Frequency Therapeutics (FREQ) United States $0.562B 0.00
Athersys (ATHX) United States $0.560B 0.00
AnaptysBio (ANAB) United States $0.543B 0.00
UROGEN PHARMA (URGN) United States $0.535B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
Clovis Oncology (CLVS) United States $0.529B 0.00
DBV Technologies S.A (DBVT) France $0.523B 0.00
AC Immune SA (ACIU) Switzerland $0.521B 0.00
VBI Vaccines (VBIV) United States $0.501B 0.00
Anika Therapeutics (ANIK) United States $0.497B 15.97
Autolus Therapeutics (AUTL) United Kingdom $0.486B 0.00
BioDelivery Sciences (BDSI) United States $0.480B 25.26
Xenon Pharmaceuticals (XENE) Canada $0.468B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.466B 0.00
Protagonist Therapeutics (PTGX) United States $0.462B 0.00
Prothena (PRTA) Ireland $0.461B 0.00
Agenus (AGEN) United States $0.460B 0.00
Cel-Sci (CVM) United States $0.459B 0.00
Dynavax Technologies (DVAX) United States $0.455B 0.00
Syros Pharmaceuticals (SYRS) United States $0.446B 0.00
Intrexon (PGEN) United States $0.429B 0.00
Puma Biotechnology (PBYI) United States $0.425B 0.00
Seres Therapeutics (MCRB) United States $0.417B 0.00
CytomX Therapeutics (CTMX) United States $0.415B 0.00
Merus (MRUS) Netherlands $0.414B 0.00
Albireo Pharma (ALBO) United States $0.409B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.403B 0.00
MiMedx (MDXG) United States $0.401B 0.00
PDL BioPharma (PDLI) United States $0.387B 332.00
ANI Pharmaceuticals (ANIP) United States $0.383B 7.58
Precision BioSciences (DTIL) United States $0.364B 0.00
WAVE Life Sciences (WVE) Singapore $0.363B 0.00
Kamada (KMDA) Israel $0.350B 14.56
Selecta Biosciences (SELB) United States $0.338B 0.00
Menlo Therapeutics (MNLO) United States $0.331B 0.00
Geron (GERN) United States $0.329B 0.00
MannKind (MNKD) United States $0.324B 0.00
OSMOTICA PHARM (OSMT) United States $0.309B 0.00
Avid Bioservices (CDMO) United States $0.308B 0.00
ChromaDex (CDXC) United States $0.294B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.292B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.285B 0.00
Verastem (VSTM) United States $0.284B 0.00
Starpharma Holdings (SPHRY) Australia $0.281B 0.00
Abeona Therapeutics (ABEO) United States $0.276B 0.00
Cellular Biomedicine (CBMG) United States $0.266B 0.00
Aduro Biotech (ADRO) United States $0.265B 0.00
ADMA Biologics Inc (ADMA) United States $0.262B 0.00
Liquidia Technologies (LQDA) United States $0.257B 0.00
Fortress Biotech (FBIO) United States $0.247B 0.00
HOOKIPA Pharma (HOOK) United States $0.246B 0.00
Spero Therapeutics (SPRO) United States $0.245B 0.00
Gritstone Oncology (GRTS) United States $0.244B 0.00
Prometic Life Sciences (LMNL) Canada $0.241B 0.00
Affimed (AFMD) Germany $0.241B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.239B 0.00
Pfenex (PFNX) United States $0.238B 0.00
Northwest Biotherapeutics (NWBO) United States $0.238B 0.00
XOMA (XOMA) United States $0.226B 0.00
Sutro Biopharma (STRO) United States $0.225B 0.00
Exicure (XCUR) United States $0.225B 0.00
Five Prime Therapeutics (FPRX) United States $0.218B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.217B 3.27
IVERIC Bio (ISEE) United States $0.210B 0.00
GENFIT S.A (GNFT) France $0.206B 0.00
VTv Therapeutics (VTVT) United States $0.200B 0.00
Pluristem Therapeutics (PSTI) Israel $0.199B 0.00
Strongbridge Biopharma (SBBP) United States $0.197B 0.00
ARAVIVE, INC (ARAV) United States $0.195B 0.00
IBio (IBIO) United States $0.192B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.190B 0.00
Aptinyx (APTX) United States $0.180B 0.00
Kindred Biosciences (KIN) United States $0.179B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.178B 0.00
Aytu Bioscience (AYTU) United States $0.173B 0.00
Dyadic (DYAI) United States $0.166B 0.00
TELA Bio (TELA) United States $0.164B 0.00
Cerecor (CERC) United States $0.163B 0.00
Theratechnologies (THTX) Canada $0.159B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.159B 0.00
Antibe Therapeutics (ATBPF) Canada $0.159B 0.00
Arbutus Biopharma (ABUS) Canada $0.153B 0.00
Orgenesis (ORGS) United States $0.151B 0.00
Trevena (TRVN) United States $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Cidara Therapeutics (CDTX) United States $0.148B 0.00
Biofrontera AG (BFRA) Germany $0.146B 0.00
Enzo Biochem (ENZ) United States $0.142B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.141B 0.00
Celyad SA (CYAD) Belgium $0.137B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.136B 0.00
Applied Genetic Technologies (AGTC) United States $0.130B 0.00
VolitionRX (VNRX) United States $0.129B 0.00
PHASEBIO PHARMA (PHAS) United States $0.127B 0.00
CorMedix Inc (CRMD) United States $0.127B 0.00
Palatin Technologies (PTN) United States $0.126B 3.23
Checkpoint Therapeutics (CKPT) United States $0.124B 0.00
AIT Therapeutics (XAIR) United States $0.124B 0.00
Lumos Pharma (LUMO) United States $0.122B 0.00
Cyclerion Therapeutics (CYCN) United States $0.121B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.113B 0.00
Protalix BioTherapeutics (PLX) Israel $0.111B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.110B 0.00
Eton Pharmaceuticals (ETON) United States $0.101B 0.00
Oncobiologics (OTLK) United States $0.096B 0.00
Windtree Therapeutics (WINT) United States $0.096B 0.00
Catalyst Biosciences (CBIO) United States $0.095B 0.00
Clearside Biomedical (CLSD) United States $0.093B 0.00
AquaBounty Technologies (AQB) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.091B 0.00
AnPac Bio-Medical Science (ANPC) China $0.085B 0.00
Celsion (CLSN) United States $0.085B 0.00
Synlogic (SYBX) United States $0.080B 0.00
Organovo Holdings (ONVO) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Proteostasis Therapeutics (PTI) United States $0.077B 0.00
Stealth BioTherapeutics (MITO) United States $0.073B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.071B 0.00
Happiness Biotech Group (HAPP) China $0.067B 0.00
Emmaus Life Sciences (EMMA) United States $0.065B 0.00
DiaMedica Therapeutics (DMAC) United States $0.063B 0.00
Vaccinex (VCNX) United States $0.063B 0.00
Idera Pharmaceuticals (IDRA) United States $0.061B 0.00
Ecology Coatings (ABVC) United States $0.057B 0.00
CollPlant Holdings (CLGN) Israel $0.057B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.055B 0.00
Soligenix (SNGX) United States $0.054B 0.00
Apricus Biosciences (SEEL) United States $0.053B 0.00
Cocrystal Pharma (COCP) United States $0.052B 0.00
Celldex Therapeutics (CLDX) United States $0.050B 0.00
Prima BioMed (IMMP) Australia $0.050B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.049B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Pulmatrix (PULM) United States $0.047B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.047B 0.00
Signal Genetics (MGEN) United States $0.045B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Advaxis (ADXS) United States $0.043B 0.00
OvaScience (MLND) United States $0.040B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.038B 0.00
Cesca Therapeutics (THMO) United States $0.038B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
TOCAGEN INC (TOCA) United States $0.034B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.032B 0.00
Curis (CRIS) United States $0.030B 0.00
BioCardia (BCDA) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
TrovaGene (CRDF) United States $0.028B 0.00
Evogene (EVGN) Israel $0.028B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Spherix (AIKI) United States $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
Cleveland BioLabs (CBLI) United States $0.024B 0.00
Entera Bio (ENTX) Israel $0.023B 0.00
VIVUS (VVUS) United States $0.022B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.020B 0.00
Bionano Genomics (BNGO) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.016B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Neuralstem (SNCA) United States $0.008B 0.00
IMMURON (IMRN) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (TMBR) United States $0.004B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00